The Antimicrobial Peptide MPX Promotes the Maturation of Dendritic Cells by Enhancing Glycolysis

Xiaowei Du, Bo Wen, Ruibiao Wang, Chengshui Liao, Weiyu Luo, Wěi Zhāng, Chunling Zhu, Yuliang Wen, Huarun Sun, Longfei Zhang, Xuehan Liu, Jiyuan Shen, Yundi Wu, Xilong Wu, Hao Li, Jianhe Hu, Yueyu Bai, Ke Ding, Lei WangResearch Square 2025 · DOI

TL;DR

Researchers have discovered that the wasp venom-derived peptide MPX does more than just kill bacteria—it acts as a metabolic "switch" for the immune system. By boosting glycolysis in dendritic cells, MPX triggers their maturation and enhances their ability to activate T-cells, offering a promising dual-action strategy for immunotherapy and infection control.

What Problem Does This Paper Address?

Antimicrobial peptides (AMPs) are well-known for their ability to punch holes in bacterial membranes. However, scientists are increasingly realizing that AMPs also function as "immunomodulators," signaling the host's own immune cells to join the fight.

Dendritic cells (DCs) are the "generals" of the immune system; they capture pathogens and present them to T-cells to initiate a targeted attack. While some AMPs are known to activate DCs, the specific molecular "how" behind the wasp-derived peptide MPX remained a mystery. This paper investigates whether MPX influences DC maturation by altering their internal metabolism—specifically, how they process energy.

Methods

The authors employed a multi-disciplinary approach to track MPX’s journey from the cell surface to the nucleus:

  • Cellular Imaging: Used FITC-labeled MPX and laser confocal microscopy to observe the peptide being internalized by mouse-derived dendritic cells (DC2.4 line).
  • Phenotyping: Standard assays (Western Blot and RT-qPCR) measured the expression of maturation markers like CD80, CD86, and MHC molecules.
  • Metabolic Profiling: The team measured glucose uptake, ATP production, and levels of lactate and pyruvate to determine if the cells were shifting their energy production strategy.
  • Transcriptomics: RNA-seq (Illumina NovaSeq 6000) was used to identify the 90 differentially expressed genes (DEGs) triggered by MPX treatment.
  • Functional Validation: An Allogeneic Mixed Lymphocyte Reaction (MLR) tested whether MPX-treated DCs could actually stimulate T-cell proliferation. They also used a Nos2 agonist (ferrous citrate) to verify if downregulating this specific gene was the key to MPX's metabolic effects.

Datasets

The primary data generated was the transcriptomic profile of MPX-treated dendritic cells.

  • RNA-seq Data: Uploaded to the NCBI SRA database under accession IDs SRR31850248–SRR31850253.
  • Cell Line: The study utilized the DC2.4 bone marrow-derived dendritic cell line, a standard model for murine immunology.

Key Insights and Ideas

  • The Glycolytic Shift: The most significant finding is that MPX forces DCs to switch from oxidative phosphorylation (efficient but slow) to glycolysis (fast, "emergency" energy). This metabolic reprogramming is a hallmark of immune cell activation, providing the raw materials needed for rapid protein synthesis and cytokine secretion.
  • Internalization is Key: Unlike some AMPs that act solely on the membrane, MPX is internalized by DCs in a time-dependent manner, suggesting it interacts with internal signaling pathways.
  • Nos2 as a Metabolic Brake: The study identified Nos2 as a downregulated gene under MPX treatment. By "releasing the brake" provided by Nos2, MPX appears to facilitate the surge in glycolysis required for maturation.
  • Controlled Inflammation: Interestingly, while MPX significantly boosted pro-inflammatory cytokines like IL-1β and IL-18, it had a relatively mild effect on TNF-α. This suggests MPX might promote a potent but controlled immune response compared to harsher triggers like LPS (bacterial endotoxin).

Key Results

  • Optimal Dosing: MPX showed the strongest activation of maturation markers at 10 µg/mL over a 12-hour period.
  • Metabolic Surge: MPX-treated cells showed significantly higher lactate production, increased glucose uptake, and higher ATP levels. Key glycolytic genes GLUT1 and HK2 were markedly upregulated.
  • T-Cell Activation: In co-culture experiments, DCs treated with MPX significantly increased the "Stimulation Index" of T-cells, proving that the phenotypic changes translated into functional immune power.
  • Gene Expression: RNA-seq identified 90 DEGs (67 downregulated, 23 upregulated), with enrichment heavily focused on metabolic and biosynthetic pathways.

Limitations and Future Work

While the results are compelling, the study was conducted entirely in vitro using a specific mouse cell line. The authors acknowledge that:

  1. In Vivo Validation: The next step is to see if MPX can trigger similar DC maturation and T-cell recruitment in living animal models of infection or cancer.
  2. Receptor Identification: While the paper shows MPX enters the cell, the specific surface receptors it binds to initially remain unidentified.
  3. Clinical Translation: Further studies are needed to ensure that the metabolic shift induced by MPX doesn't have unintended long-term effects on cell longevity or systemic inflammation.

Summary updated

Abstract

<title>Abstract</title> Antimicrobial peptide MPX is derived from wasp venom, known for its antibacterial activity against a wide range of bacteria. Researches have indicated that antimicrobial peptide could induce dendritic cell maturation through interaction with surface receptors, thereby activating antigen presentation and initiating immune responses, which indirectly contributes to antimicrobial effects. However, the specific mechanism by which the antimicrobial peptide MPX activates dendritic cells remains unclear. The aim of this study was to investigate how MPX activates dendritic cells and thus enhances antigen presentation.In the present study, it was found that dendritic cells exhibited a time-dependent internalization of the antimicrobial peptide MPX. MPX internalized by dendritic cells increased the expression of maturation markers such as CD80, CD86, and promoted the secretion of the pro-inflammatory factors IL-1β and IL-18, whereas it had a relatively mild effect on TNF-α.Furthermore, MPX also altered metabolic pathways of dendritic cells, favoring glycolysis and thereby activating them to subsequently promote CTL cell proliferation. To explore the molecular mechanisms underlying MPX’s regulation of dendritic cell activation, RNA-seq analysis was performed. The results showed that following MPX treatment dendritic cells exhibited had 90 differentially expressed genes (DEGs) compared to the control group, with enrichment observed in metabolism and biosynthesis processes. These findings not only provide insights into the potential applications of MPX in infection control but also emphasize its significant role in dendritic cell-mediated immune responses. In summary, this study has demonstrated that the MPX can activate dendritic cells, promote T-cell proliferation, and present new avenues for utilizing antimicrobial peptides in immune modulation within the host.
BibTeX
@inproceedings{du2025antimicrobial,
  author = {Xiaowei Du and Bo Wen and Ruibiao Wang and Chengshui Liao and Weiyu Luo and Wěi Zhāng and Chunling Zhu and Yuliang Wen and Huarun Sun and Longfei Zhang and Xuehan Liu and Jiyuan Shen and Yundi Wu and Xilong Wu and Hao Li and Jianhe Hu and Yueyu Bai and Ke Ding and Lei Wang},
  title = {{The Antimicrobial Peptide MPX Promotes the Maturation of Dendritic Cells by Enhancing Glycolysis}},
  booktitle = {Research Square},
  year = {2025},
  doi = {10.21203/rs.3.rs-5867452/v1},
}
Figure